Penumbra has today announced the promotion of Shruthi Narayan to president of the company, effective 1 September 2025.
A recent company press release states she will continue to report to Adam Elsesser, who served in the role of president prior to this promotion and will continue in his role as both chairman of the board and chief executive officer of Penumbra.
“Shruthi is a dynamic, seasoned leader whose passion for innovation and proven ability to inspire global teams make her the obvious choice for this critical role,” said Elsesser. “Her vision and focus on excellence will undoubtedly help sustain Penumbra’s exceptional growth and market leadership, expanding access to our life-saving technology to patients around the world.”
A 20-year veteran in the medical device industry, Narayan was most recently president of Penumbra’s interventional business where she led the day-to-day operations and oversaw the growth initiatives of both the company’s neuro and vascular franchises.
She joined Penumbra in 2013 as a product manager starting off on the stroke franchise, then transitioning to help build the peripheral vascular division, commercialising Penumbra’s vascular portfolio of embolization and thrombectomy products globally. Narayan began her medical device career at Medtronic in 2006, working in engineering, regulatory affairs, and then, in the cardiovascular sales organisation.
“Penumbra has been at the forefront of blood clot care for more than 20 years, advancing the most innovative technologies to address conditions from head-to-toe like stroke and pulmonary embolism,” said Narayan. “I am honoured to carry on and expand our legacy of innovation and look forward to continuing this paradigm shift in patient care.”
